Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |